Ligand validation:4BVN

MHA: (CARBAMOYLMETHYL-CARBOXYMETHYL-AMINO)-ACETIC ACID

MHA is a Ligand Of Interest in 4BVN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BVN_MHA_A_1362	30%	35%	0.198	0.861	1.77	0.91	2	1	0	0	100%	1
5A8E_MHA_A_801	54%	41%	0.157	0.921	0.96	1.4	-	2	0	0	100%	1
6QLM_MHA_B_302	91%	29%	0.081	0.966	0.94	2.04	-	3	0	0	100%	0.9
5HWE_MHA_A_403	79%	37%	0.092	0.939	1.1	1.45	1	3	0	0	100%	1
6AJH_MHA_A_1007	72%	33%	0.14	0.964	1.31	1.44	1	2	1	0	100%	1
5HXU_MHA_A_402	69%	23%	0.114	0.928	1.71	1.62	3	2	0	0	100%	1
1IX1_MHA_B_1401	67%	14%	0.13	0.94	1.79	2.29	4	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.